Sutherland DEK - Search Results

1

Efficacy of ¹⁷⁷Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study.

Sistani G, Sutherland DEK, Mujoomdar A, Wiseman DP, Khatami A, Tsvetkova E, Reid RH, Laidley DT. Sistani G, et al. Among authors: sutherland dek. Curr Oncol. 2020 Dec 21;28(1):115-127. doi: 10.3390/curroncol28010015. Curr Oncol. 2020. PMID: 33622997 Free PMC article. Clinical Trial.

2

Survival predictors of ¹⁷⁷Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS).

Swiha MM, Sutherland DEK, Sistani G, Khatami A, Abazid RM, Mujoomdar A, Wiseman DP, Romsa JG, Reid RH, Laidley DT. Swiha MM, et al. Among authors: sutherland dek. J Cancer Res Clin Oncol. 2022 Jan;148(1):225-236. doi: 10.1007/s00432-021-03672-w. Epub 2021 Jun 10. J Cancer Res Clin Oncol. 2022. PMID: 34110489 Free PMC article. Clinical Trial.

3

Toxicity and Tolerability of ¹⁷⁷Lu-DOTA-TATE PRRT with a Modified Administered Activity Protocol in NETs of Variable Origin - A Phase 2 Registry Study.

Khatami A, Sistani G, Sutherland DEK, DeBrabandere S, Reid RH, Laidley DT. Khatami A, et al. Among authors: sutherland dek. Curr Radiopharm. 2022;15(2):123-133. doi: 10.2174/1874471014666210810100435. Curr Radiopharm. 2022. PMID: 35135467 Free PMC article.

4

A rare presentation of SLE coronary vascular disease detected on Tc-99 m MDP bone scan SPECT CT.

Sutherland D, Ahmed K, Abazid R, Akincioglu C, Warrington J, Goela A, Laidley D, Stodilka R, Vezina W, Romsa J. Sutherland D, et al. J Cardiovasc Comput Tomogr. 2021 Sep-Oct;15(5):e98-e100. doi: 10.1016/j.jcct.2021.03.011. Epub 2021 Apr 6. J Cardiovasc Comput Tomogr. 2021. PMID: 33865744 No abstract available.

5

It's a small world after all: A Canadian resident's perspective on COVID-19.

Sutherland DEK. Sutherland DEK. J Nucl Cardiol. 2020 Dec;27(6):2283-2286. doi: 10.1007/s12350-020-02222-0. Epub 2020 Jun 28. J Nucl Cardiol. 2020. PMID: 32596790 Free PMC article.

6

Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases.

Climans SA, Macdonald DR, Sutherland DE, Mason WP. Climans SA, et al. BMJ Case Rep. 2020 Oct 29;13(10):e236406. doi: 10.1136/bcr-2020-236406. BMJ Case Rep. 2020. PMID: 33122230 Free PMC article.

7

Modeling the Zn(2+) and Cd(2+) metalation mechanism in mammalian metallothionein 1a.

Sutherland DE, Summers KL, Stillman MJ. Sutherland DE, et al. Biochem Biophys Res Commun. 2012 Oct 5;426(4):601-7. doi: 10.1016/j.bbrc.2012.08.136. Epub 2012 Sep 6. Biochem Biophys Res Commun. 2012. PMID: 22982309

8

Single domain metallothioneins: supermetalation of human MT 1a.

Sutherland DE, Willans MJ, Stillman MJ. Sutherland DE, et al. J Am Chem Soc. 2012 Feb 15;134(6):3290-9. doi: 10.1021/ja211767m. Epub 2012 Feb 6. J Am Chem Soc. 2012. PMID: 22242602

9

Single-domain metallothioneins: evidence of the onset of clustered metal binding domains in Zn-rhMT 1a.

Summers KL, Sutherland DE, Stillman MJ. Summers KL, et al. Biochemistry. 2013 Apr 9;52(14):2461-71. doi: 10.1021/bi400021b. Epub 2013 Mar 29. Biochemistry. 2013. PMID: 23506369

10

Noncooperative metalation of metallothionein 1a and its isolated domains with zinc.

Sutherland DE, Summers KL, Stillman MJ. Sutherland DE, et al. Biochemistry. 2012 Aug 21;51(33):6690-700. doi: 10.1021/bi3004523. Epub 2012 Aug 7. Biochemistry. 2012. PMID: 22823575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page